Purchases and Sales Made in Q4 2021 in G1 Therapeutics, Inc. (GTHX)
This table provides information about the institutional ownership of G1 Therapeutics, Inc. (GTHX) during Q4 2021. The information is specifically focused on institutions that hold shares of G1 Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-82K- 1.87% |
$833K - $1.33M
|
4.3M
$30.8M
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-96K- 4.29% |
$975K - $1.55M
|
2.14M
$15.3M
|
|
|
Feb 14, 2022
Q4 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-110K- 32.42% |
$1.12M - $1.78M
|
229K
$1.64M
|
|
|
Feb 14, 2022
Q4 2021
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-113K- 88.22% |
$1.15M - $1.82M
|
15.1K
$108K
|
|
|
Jan 21, 2022
Q4 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-157KClosed |
$1.59M - $2.53M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Tekla Capital Management LLC
|
SELL
|
- |
-201K- 32.11% |
$2.04M - $3.24M
|
424K
$3.03M
|
|
|
Feb 14, 2022
Q4 2021
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-208K- 86.01% |
$2.11M - $3.36M
|
33.9K
$242K
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-304K- 44.17% |
$3.09M - $4.91M
|
384K
$2.75M
|